Legal Representation
Attorney
Cheryl L. Foytlin
USPTO Deadlines
Application History
33 events| Date | Code | Type | Description |
|---|---|---|---|
| Oct 28, 2019 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Oct 28, 2019 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Feb 6, 2019 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Feb 5, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Feb 4, 2019 | EX5G | S | SOU EXTENSION 5 GRANTED |
| Jan 31, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jan 31, 2019 | EXT5 | S | SOU EXTENSION 5 FILED |
| Aug 7, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Aug 3, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Aug 3, 2018 | EXT4 | S | SOU EXTENSION 4 FILED |
| Aug 3, 2018 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Feb 6, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Feb 2, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Feb 2, 2018 | EXT3 | S | SOU EXTENSION 3 FILED |
| Feb 2, 2018 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Aug 29, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Aug 28, 2017 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Aug 28, 2017 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Aug 18, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Aug 18, 2017 | EXT2 | S | SOU EXTENSION 2 FILED |
| Feb 7, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Feb 3, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Feb 3, 2017 | EXT1 | S | SOU EXTENSION 1 FILED |
| Feb 3, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Feb 3, 2017 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Sep 27, 2016 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Aug 2, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Aug 2, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jul 13, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jun 24, 2016 | DOCK | D | ASSIGNED TO EXAMINER |
| Jun 24, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Mar 17, 2016 | NWAP | I | NEW APPLICATION ENTERED |
| Mar 17, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Detailed Classifications
Class 005
human pharmaceutical preparations for the treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic disorders, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases and respiratory diseases
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005